Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery

L Peura, K Malmioja, K Laine, J Leppänen…

Index: Molecular Pharmaceutics, , vol. 8, # 5 p. 1857 - 1866

Full Text: HTML

Citation Number: 37

Abstract

... Pharmaceutics , 2011, 8 (5), pp 1857–1866. DOI: 10.1021/mp2001878. Publication Date (Web): July 19 ... small molecular weight drugs and practically none of the large molecular weight drugs ... Consequently, several drug molecules in clinical use such as melfalan,(8) gabapentin,(9 ...

Related Articles:

Asymmetric synthesis of conformationally restricted L-arginine analogues as active site probes of nitric oxide synthase

[Journal of Organic Chemistry, , vol. 64, # 10 p. 3467 - 3475]

Asymmetric synthesis of conformationally restricted L-arginine analogues as active site probes of nitric oxide synthase

[Journal of Organic Chemistry, , vol. 64, # 10 p. 3467 - 3475]

Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationship.

[Chemical and Pharmaceutical Bulletin, , vol. 41, # 6 p. 1079 - 1090]

Synthesis of highly. mu. and. delta. opioid receptor-selective peptides containing a photoaffinity group

[Journal of Medicinal Chemistry, , vol. 32, # 3 p. 638 - 643]

A general Staudinger protocol for solution-phase parallel synthesis

[Tetrahedron Letters, , vol. 43, # 25 p. 4467 - 4470]

More Articles...